Safety and Efficacy of Zicronapine in Patients With Schizophrenia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the effect of zicronapine versus risperidone on metabolic parameters comprising
body weight, body mass index (BMI), waist circumference, levels of fasting blood lipids and
glucose during 6 months of treatment.